Clinical Trial Update: Analysis of 18F-AV-1451 PET Imaging in Cognitively Healthy, MCI, and AD Subjects [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 clinical trial update for 18F-AV-1451 PET imaging in cognitively healthy, mild cognitive impairment, and Alzheimer's disease subjects; study completed…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• 18F-AV-1451 (flortaucipir)

Snippet

Sponsor: Avid Radiopharmaceuticals | Conditions: Alzheimer's Disease | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2020-08-24